BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ATOSSA THERAPEUTICS\, INC. readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of studies ATOSSA THERAPEUTICS\, INC.'s drug
 s run\, from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05607004-9122@assetmemo.bio
DTSTAMP:20261121T005932Z
DTSTART;VALUE=DATE:20261130
DTEND;VALUE=DATE:20261201
SUMMARY:(Z)-endoxifen: Phase 2 readout est. (NCT05607004)
DESCRIPTION:(Z)-endoxifen\, phase 2\, Breast Cancer.\nStudy: (Z)-Endoxifen 
 for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer\nEst
 imated primary completion: November 2026. This is a ClinicalTrials.gov est
 imate\, not a confirmed readout date\, and it can move.\nDrug page: https:
 //assetmemo.bio/drug/z-endoxifen#upcoming-events\nRegistry record: https:/
 /clinicaltrials.gov/study/NCT05607004
URL:https://assetmemo.bio/drug/z-endoxifen#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07869732-9122@assetmemo.bio
DTSTAMP:20261121T005932Z
DTSTART;VALUE=DATE:20280630
DTEND;VALUE=DATE:20280701
SUMMARY:(Z)-endoxifen: Phase 2 readout est. (NCT07869732)
DESCRIPTION:(Z)-endoxifen\, phase 2.\nStudy: (Z)-Endoxifen in Girls With MA
 S-Associated Peripheral Precocious Puberty\nEstimated primary completion: 
 June 2028. This is a ClinicalTrials.gov estimate\, not a confirmed readout
  date\, and it can move.\nDrug page: https://assetmemo.bio/drug/z-endoxife
 n#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT07
 869732
URL:https://assetmemo.bio/drug/z-endoxifen#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
